TLSI Q4 2025 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+59.8% YoY

Gross Profit

$11M86.7% margin

Operating Income

-$3M-24.8% margin

Net Income

-$10M-73.9% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+14.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$35M

Total Liabilities

$69M

Stockholders' Equity

-$34M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$8M	+59.8%
Gross Profit	$11M	$7M	+62.4%
Operating Income	-$3M	-$8M	+56.8%
Net Income	-$10M	-$10M	+3.5%